Doctor Herbert Himmel
Bayer AG, Wuppertal (Germany)
Lack of pro-arrhythmic potential for the novel soluble guanylate cyclase stimulator vericiguat: results from preclinical studies
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Chronic heart failure e-posters
ESC 365 is supported by
